Skip to main content
eScholarship
Open Access Publications from the University of California

Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis

  • Author(s): Peterson, Johanna
  • Tefft, Kimberly
  • Blackmon, Joseph
  • Rajpara, Anand
  • Fraga, Garth
  • et al.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License
Abstract

Syringocystadenocarcinoma papilliferum (SCACP) is a rare adenexal carcinoma with only 21 cases reported in the literature. Most patients describe a long-standing mass with recent change, supporting the idea that SCACP arises from malignant transformation of pre-existing syringocystadenoma papilliferum (SCAP). Syringocystadenocarcinoma papilliferum is generally treated with wide surgical excision of the lesion and patients do exceeding well and require no systemic therapy.

Main Content
Current View